Barbara Duncan
2014
In 2014, Barbara Duncan earned a total compensation of $1.3M as Chief Financial Officer and Treasurer at Intercept Pharmaceuticals, a 7% decrease compared to previous year.
Compensation breakdown
| Bonus | $148,125 |
|---|---|
| Option Awards | $354,945 |
| Salary | $372,500 |
| Stock Awards | $400,079 |
| Other | $8,527 |
| Total | $1,284,176 |
Duncan received $400.1K in stock awards, accounting for 31% of the total pay in 2014.
Duncan also received $148.1K in bonus, $354.9K in option awards, $372.5K in salary and $8.5K in other compensation.
Rankings
In 2014, Barbara Duncan's compensation ranked 6,473rd out of 13,032 executives tracked by ExecPay. In other words, Duncan earned more than 50.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,473 out of 13,032 | 50th |
Division Manufacturing | 2,356 out of 4,965 | 53rd |
Major group Chemicals And Allied Products | 790 out of 1,690 | 53rd |
Industry group Drugs | 617 out of 1,369 | 55th |
Industry Pharmaceutical Preparations | 469 out of 1,042 | 55th |
Source: SEC filing on June 20, 2016.
Duncan's colleagues
We found four more compensation records of executives who worked with Barbara Duncan at Intercept Pharmaceuticals in 2014.